Omada Health (OMDA) Stock Price Target 2026

The average analyst price target for Omada Health is $26.27, 74.1% above the current price. Of 12 analysts, 11 rate it Buy and 1 Hold. Targets range from $18 to $35. The latest change came on Nov 6, 2026, when Barclays lowered its price target on Omada Health from $24 to $22 and kept an Overweight rating.

The Average Analyst Price Target for Omada Health is $26.27.

Price Target Range — 6 Quarters

Analyst Consensus — 12 Analysts

1S.Buy

10Buy

1Hold

Consensus RatingBuy# Analysts12Avg. Consensus PT$26.27Upside to Avg. PT+74.1%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Omada Health Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 6, 2026	Barclays	Saket Kalia	PT Cut	Overweight	$24→$22
Nov 6, 2026	Wells Fargo	Stan Berenshteyn	PT Cut	Equal-Weight	$22→$19
Oct 28, 2026	Barclays	Saket Kalia	PT Cut	Overweight	$27→$24
Oct 14, 2026	Freedom Capital Markets	Gene Mannheimer	Maintained	Buy	$35
Sep 14, 2026	Freedom Capital Markets	Gene Mannheimer	Maintained	Buy	$35
Sep 11, 2026	Barclays	Saket Kalia	PT Raise	Overweight	$25→$27
Sep 11, 2026	Needham	Ryan MacDonald	Maintained	Buy	$28
Sep 11, 2026	BTIG	David Larsen	Maintained	Buy	$35
Aug 14, 2026	JP Morgan	Lisa Gill	PT Raise	Overweight	$26→$30
Aug 14, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$27→$32
Aug 12, 2026	Baird	Vikram Kesavabhotla	PT Raise	Neutral	$15→$25
Aug 10, 2026	BTIG	David Larsen	PT Raise	Buy	$30→$35
Aug 3, 2026	Barclays	Saket Kalia	PT Raise	Overweight	$20→$25
Jul 21, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$24→$28
Jul 20, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$21→$27
Jul 17, 2026	BTIG	David Larsen	Initiate	Buy	$30
Jun 22, 2026	Morgan Stanley	Craig Hettenbach	Maintained	Overweight	$30
May 8, 2026	Barclays	Saket Kalia	PT Raise	Overweight	$18→$20
May 8, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$18→$21
May 8, 2026	Evercore ISI Group	Elizabeth Anderson	PT Raise	Outperform	$15→$20